nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Rifampicin—leprosy	0.108	0.163	CbGbCtD
Mirtazapine—CYP2C8—Dapsone—leprosy	0.0894	0.135	CbGbCtD
Mirtazapine—CYP1A2—Thalidomide—leprosy	0.0865	0.13	CbGbCtD
Mirtazapine—CYP1A2—Rifampicin—leprosy	0.0838	0.126	CbGbCtD
Mirtazapine—CYP2C9—Thalidomide—leprosy	0.078	0.117	CbGbCtD
Mirtazapine—CYP2C9—Rifampicin—leprosy	0.0755	0.114	CbGbCtD
Mirtazapine—CYP2C9—Dapsone—leprosy	0.0623	0.0939	CbGbCtD
Mirtazapine—CYP3A4—Rifampicin—leprosy	0.0439	0.0661	CbGbCtD
Mirtazapine—CYP3A4—Dapsone—leprosy	0.0362	0.0546	CbGbCtD
Mirtazapine—HTR3A—cranial nerve—leprosy	0.0085	0.0883	CbGeAlD
Mirtazapine—HRH1—nose—leprosy	0.00734	0.0763	CbGeAlD
Mirtazapine—HTR7—cranial nerve—leprosy	0.0055	0.0571	CbGeAlD
Mirtazapine—Lacrimal structural disorder—Thalidomide—leprosy	0.00528	0.022	CcSEcCtD
Mirtazapine—Thromboembolism—Thalidomide—leprosy	0.00488	0.0204	CcSEcCtD
Mirtazapine—HTR2A—trigeminal nerve—leprosy	0.00481	0.05	CbGeAlD
Mirtazapine—HTR3A—nerve—leprosy	0.00436	0.0453	CbGeAlD
Mirtazapine—Dementia—Thalidomide—leprosy	0.00378	0.0158	CcSEcCtD
Mirtazapine—SLC6A3—nerve—leprosy	0.00362	0.0377	CbGeAlD
Mirtazapine—HTR7—peripheral nervous system—leprosy	0.00362	0.0376	CbGeAlD
Mirtazapine—Lacrimal disorder—Thalidomide—leprosy	0.00347	0.0145	CcSEcCtD
Mirtazapine—HTR2A—cranial nerve—leprosy	0.00343	0.0356	CbGeAlD
Mirtazapine—Aphthous stomatitis—Thalidomide—leprosy	0.00331	0.0138	CcSEcCtD
Mirtazapine—Paraesthesia oral—Thalidomide—leprosy	0.00331	0.0138	CcSEcCtD
Mirtazapine—Grand mal convulsion—Thalidomide—leprosy	0.00326	0.0136	CcSEcCtD
Mirtazapine—Neck stiffness—Thalidomide—leprosy	0.00326	0.0136	CcSEcCtD
Mirtazapine—Cerebral ischaemia—Thalidomide—leprosy	0.00321	0.0134	CcSEcCtD
Mirtazapine—Tongue discolouration—Thalidomide—leprosy	0.00321	0.0134	CcSEcCtD
Mirtazapine—Embolism venous—Thalidomide—leprosy	0.00307	0.0128	CcSEcCtD
Mirtazapine—Nuchal rigidity—Thalidomide—leprosy	0.00299	0.0125	CcSEcCtD
Mirtazapine—SLC6A2—nerve—leprosy	0.00292	0.0304	CbGeAlD
Mirtazapine—HTR2A—hindlimb—leprosy	0.00289	0.03	CbGeAlD
Mirtazapine—HTR7—nerve—leprosy	0.00282	0.0293	CbGeAlD
Mirtazapine—Hostility—Thalidomide—leprosy	0.0028	0.0117	CcSEcCtD
Mirtazapine—DRD2—nerve—leprosy	0.00266	0.0277	CbGeAlD
Mirtazapine—ADRA2A—peripheral nervous system—leprosy	0.00265	0.0275	CbGeAlD
Mirtazapine—Enlargement abdomen—Thalidomide—leprosy	0.00258	0.0108	CcSEcCtD
Mirtazapine—HTR2A—appendage—leprosy	0.00248	0.0258	CbGeAlD
Mirtazapine—Myasthenia—Thalidomide—leprosy	0.00247	0.0103	CcSEcCtD
Mirtazapine—Oral candidiasis—Thalidomide—leprosy	0.00244	0.0102	CcSEcCtD
Mirtazapine—Embolism—Thalidomide—leprosy	0.00242	0.0101	CcSEcCtD
Mirtazapine—Hypothyroidism—Thalidomide—leprosy	0.00242	0.0101	CcSEcCtD
Mirtazapine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00228	0.00949	CcSEcCtD
Mirtazapine—Intestinal obstruction—Thalidomide—leprosy	0.00228	0.00949	CcSEcCtD
Mirtazapine—HTR2A—peripheral nervous system—leprosy	0.00225	0.0234	CbGeAlD
Mirtazapine—HTR7—blood vessel—leprosy	0.00221	0.023	CbGeAlD
Mirtazapine—Metrorrhagia—Thalidomide—leprosy	0.00217	0.00906	CcSEcCtD
Mirtazapine—Nystagmus—Thalidomide—leprosy	0.00217	0.00906	CcSEcCtD
Mirtazapine—Hyperlipidaemia—Thalidomide—leprosy	0.00215	0.00898	CcSEcCtD
Mirtazapine—Psychotic disorder—Dapsone—leprosy	0.00215	0.00896	CcSEcCtD
Mirtazapine—Stupor—Thalidomide—leprosy	0.00208	0.00867	CcSEcCtD
Mirtazapine—DRD4—testis—leprosy	0.00205	0.0213	CbGeAlD
Mirtazapine—HRH3—nervous system—leprosy	0.00204	0.0212	CbGeAlD
Mirtazapine—Amblyopia—Thalidomide—leprosy	0.00201	0.00838	CcSEcCtD
Mirtazapine—Skin ulcer—Thalidomide—leprosy	0.00199	0.00831	CcSEcCtD
Mirtazapine—Muscular weakness—Dapsone—leprosy	0.00194	0.00809	CcSEcCtD
Mirtazapine—Influenza—Dapsone—leprosy	0.0019	0.00793	CcSEcCtD
Mirtazapine—Petechiae—Thalidomide—leprosy	0.00189	0.00787	CcSEcCtD
Mirtazapine—Pancreatitis—Dapsone—leprosy	0.00186	0.00778	CcSEcCtD
Mirtazapine—Acne—Thalidomide—leprosy	0.00184	0.00769	CcSEcCtD
Mirtazapine—Amenorrhoea—Thalidomide—leprosy	0.00177	0.00736	CcSEcCtD
Mirtazapine—HTR2A—nerve—leprosy	0.00176	0.0183	CbGeAlD
Mirtazapine—Photosensitivity reaction—Dapsone—leprosy	0.00174	0.00724	CcSEcCtD
Mirtazapine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00173	0.00721	CcSEcCtD
Mirtazapine—Bone disorder—Thalidomide—leprosy	0.00172	0.00716	CcSEcCtD
Mirtazapine—Cellulitis—Thalidomide—leprosy	0.00171	0.00712	CcSEcCtD
Mirtazapine—Arthropathy—Thalidomide—leprosy	0.00171	0.00712	CcSEcCtD
Mirtazapine—Thinking abnormal—Thalidomide—leprosy	0.0017	0.00707	CcSEcCtD
Mirtazapine—Herpes simplex—Thalidomide—leprosy	0.00168	0.00702	CcSEcCtD
Mirtazapine—Dyskinesia—Thalidomide—leprosy	0.00165	0.00689	CcSEcCtD
Mirtazapine—Hypercholesterolaemia—Thalidomide—leprosy	0.00164	0.00684	CcSEcCtD
Mirtazapine—Bone pain—Thalidomide—leprosy	0.00162	0.00676	CcSEcCtD
Mirtazapine—Sinusitis—Dapsone—leprosy	0.00159	0.00663	CcSEcCtD
Mirtazapine—Coordination abnormal—Thalidomide—leprosy	0.00158	0.00659	CcSEcCtD
Mirtazapine—Neck pain—Thalidomide—leprosy	0.00157	0.00655	CcSEcCtD
Mirtazapine—Pulmonary embolism—Thalidomide—leprosy	0.00155	0.00647	CcSEcCtD
Mirtazapine—Eructation—Thalidomide—leprosy	0.00152	0.00636	CcSEcCtD
Mirtazapine—Pharyngitis—Dapsone—leprosy	0.00151	0.0063	CcSEcCtD
Mirtazapine—Depressed level of consciousness—Thalidomide—leprosy	0.0015	0.00625	CcSEcCtD
Mirtazapine—Colitis—Thalidomide—leprosy	0.00149	0.00621	CcSEcCtD
Mirtazapine—Candida infection—Thalidomide—leprosy	0.00148	0.00618	CcSEcCtD
Mirtazapine—Aplastic anaemia—Thalidomide—leprosy	0.00146	0.00608	CcSEcCtD
Mirtazapine—Tinnitus—Dapsone—leprosy	0.00142	0.00592	CcSEcCtD
Mirtazapine—DRD3—nervous system—leprosy	0.00142	0.0147	CbGeAlD
Mirtazapine—Pulmonary oedema—Thalidomide—leprosy	0.00138	0.00576	CcSEcCtD
Mirtazapine—HTR2A—blood vessel—leprosy	0.00138	0.0143	CbGeAlD
Mirtazapine—Hypertonia—Thalidomide—leprosy	0.00136	0.00567	CcSEcCtD
Mirtazapine—Hyperkinesia—Thalidomide—leprosy	0.00135	0.00564	CcSEcCtD
Mirtazapine—Mental disability—Thalidomide—leprosy	0.00135	0.00562	CcSEcCtD
Mirtazapine—Euphoric mood—Thalidomide—leprosy	0.00133	0.00556	CcSEcCtD
Mirtazapine—Lymphadenopathy—Thalidomide—leprosy	0.00132	0.00551	CcSEcCtD
Mirtazapine—Diabetes mellitus—Thalidomide—leprosy	0.0013	0.0054	CcSEcCtD
Mirtazapine—Gastroenteritis—Thalidomide—leprosy	0.00127	0.0053	CcSEcCtD
Mirtazapine—OPRK1—nervous system—leprosy	0.00126	0.0131	CbGeAlD
Mirtazapine—Deafness—Thalidomide—leprosy	0.00126	0.00525	CcSEcCtD
Mirtazapine—Eye pain—Thalidomide—leprosy	0.00125	0.0052	CcSEcCtD
Mirtazapine—Libido decreased—Thalidomide—leprosy	0.00121	0.00507	CcSEcCtD
Mirtazapine—Increased appetite—Thalidomide—leprosy	0.0012	0.005	CcSEcCtD
Mirtazapine—Amnesia—Thalidomide—leprosy	0.0012	0.005	CcSEcCtD
Mirtazapine—HTR2B—skin of body—leprosy	0.0012	0.0124	CbGeAlD
Mirtazapine—Dermatitis exfoliative—Thalidomide—leprosy	0.00119	0.00498	CcSEcCtD
Mirtazapine—Vertigo—Dapsone—leprosy	0.00119	0.00496	CcSEcCtD
Mirtazapine—Dermatitis bullous—Thalidomide—leprosy	0.00118	0.00491	CcSEcCtD
Mirtazapine—Arthritis—Thalidomide—leprosy	0.00116	0.00483	CcSEcCtD
Mirtazapine—Cough—Dapsone—leprosy	0.00116	0.00482	CcSEcCtD
Mirtazapine—Lethargy—Thalidomide—leprosy	0.00115	0.00479	CcSEcCtD
Mirtazapine—Hyponatraemia—Thalidomide—leprosy	0.00113	0.00472	CcSEcCtD
Mirtazapine—Diplopia—Thalidomide—leprosy	0.00113	0.0047	CcSEcCtD
Mirtazapine—Osteoarthritis—Thalidomide—leprosy	0.00113	0.0047	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Thalidomide—leprosy	0.00112	0.00466	CcSEcCtD
Mirtazapine—DRD2—eye—leprosy	0.00111	0.0116	CbGeAlD
Mirtazapine—Affect lability—Thalidomide—leprosy	0.00111	0.00462	CcSEcCtD
Mirtazapine—Migraine—Thalidomide—leprosy	0.00111	0.00462	CcSEcCtD
Mirtazapine—Psychotic disorder—Thalidomide—leprosy	0.0011	0.00459	CcSEcCtD
Mirtazapine—Face oedema—Thalidomide—leprosy	0.00109	0.00453	CcSEcCtD
Mirtazapine—Mood swings—Thalidomide—leprosy	0.00107	0.00445	CcSEcCtD
Mirtazapine—Ataxia—Thalidomide—leprosy	0.00106	0.00442	CcSEcCtD
Mirtazapine—Tachycardia—Dapsone—leprosy	0.00106	0.0044	CcSEcCtD
Mirtazapine—Dehydration—Thalidomide—leprosy	0.00105	0.00437	CcSEcCtD
Mirtazapine—Liver function test abnormal—Thalidomide—leprosy	0.00104	0.00434	CcSEcCtD
Mirtazapine—Dry skin—Thalidomide—leprosy	0.00103	0.00431	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Thalidomide—leprosy	0.00103	0.00429	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00101	0.00423	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00101	0.00423	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000993	0.00414	CcSEcCtD
Mirtazapine—Muscular weakness—Thalidomide—leprosy	0.000993	0.00414	CcSEcCtD
Mirtazapine—Abdominal distension—Thalidomide—leprosy	0.00098	0.00409	CcSEcCtD
Mirtazapine—HTR3A—nervous system—leprosy	0.00098	0.0102	CbGeAlD
Mirtazapine—Insomnia—Dapsone—leprosy	0.000978	0.00408	CcSEcCtD
Mirtazapine—Influenza—Thalidomide—leprosy	0.000974	0.00406	CcSEcCtD
Mirtazapine—Eosinophilia—Thalidomide—leprosy	0.000964	0.00402	CcSEcCtD
Mirtazapine—Pancreatitis—Thalidomide—leprosy	0.000954	0.00398	CcSEcCtD
Mirtazapine—Angina pectoris—Thalidomide—leprosy	0.000948	0.00395	CcSEcCtD
Mirtazapine—Bronchitis—Thalidomide—leprosy	0.000936	0.0039	CcSEcCtD
Mirtazapine—Pancytopenia—Thalidomide—leprosy	0.000925	0.00386	CcSEcCtD
Mirtazapine—HTR2B—tendon—leprosy	0.000911	0.00946	CbGeAlD
Mirtazapine—Neutropenia—Thalidomide—leprosy	0.00091	0.0038	CcSEcCtD
Mirtazapine—Pollakiuria—Thalidomide—leprosy	0.000899	0.00375	CcSEcCtD
Mirtazapine—Erectile dysfunction—Thalidomide—leprosy	0.000897	0.00374	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Thalidomide—leprosy	0.000889	0.00371	CcSEcCtD
Mirtazapine—Weight increased—Thalidomide—leprosy	0.000886	0.00369	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dapsone—leprosy	0.000884	0.00369	CcSEcCtD
Mirtazapine—Weight decreased—Thalidomide—leprosy	0.000881	0.00367	CcSEcCtD
Mirtazapine—HRH1—eye—leprosy	0.000879	0.00914	CbGeAlD
Mirtazapine—Pneumonia—Thalidomide—leprosy	0.000873	0.00364	CcSEcCtD
Mirtazapine—Drowsiness—Thalidomide—leprosy	0.000868	0.00362	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000861	0.00359	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Thalidomide—leprosy	0.000856	0.00357	CcSEcCtD
Mirtazapine—Abdominal pain—Dapsone—leprosy	0.000855	0.00357	CcSEcCtD
Mirtazapine—Body temperature increased—Dapsone—leprosy	0.000855	0.00357	CcSEcCtD
Mirtazapine—Myocardial infarction—Thalidomide—leprosy	0.000851	0.00355	CcSEcCtD
Mirtazapine—Stomatitis—Thalidomide—leprosy	0.000846	0.00353	CcSEcCtD
Mirtazapine—Conjunctivitis—Thalidomide—leprosy	0.000844	0.00352	CcSEcCtD
Mirtazapine—Sweating—Thalidomide—leprosy	0.000832	0.00347	CcSEcCtD
Mirtazapine—SLC6A3—testis—leprosy	0.000831	0.00863	CbGeAlD
Mirtazapine—Haematuria—Thalidomide—leprosy	0.000828	0.00345	CcSEcCtD
Mirtazapine—Epistaxis—Thalidomide—leprosy	0.000819	0.00341	CcSEcCtD
Mirtazapine—SLC6A3—nervous system—leprosy	0.000815	0.00847	CbGeAlD
Mirtazapine—Sinusitis—Thalidomide—leprosy	0.000814	0.0034	CcSEcCtD
Mirtazapine—Agranulocytosis—Thalidomide—leprosy	0.00081	0.00338	CcSEcCtD
Mirtazapine—Bradycardia—Thalidomide—leprosy	0.000793	0.00331	CcSEcCtD
Mirtazapine—HTR2C—nervous system—leprosy	0.000788	0.00819	CbGeAlD
Mirtazapine—Rhinitis—Thalidomide—leprosy	0.000781	0.00326	CcSEcCtD
Mirtazapine—HTR7—tendon—leprosy	0.00078	0.0081	CbGeAlD
Mirtazapine—Hepatitis—Thalidomide—leprosy	0.000779	0.00325	CcSEcCtD
Mirtazapine—Hypoaesthesia—Thalidomide—leprosy	0.000775	0.00323	CcSEcCtD
Mirtazapine—Pharyngitis—Thalidomide—leprosy	0.000773	0.00323	CcSEcCtD
Mirtazapine—ADRB1—nervous system—leprosy	0.000773	0.00803	CbGeAlD
Mirtazapine—Urinary tract disorder—Thalidomide—leprosy	0.00077	0.00321	CcSEcCtD
Mirtazapine—Oedema peripheral—Thalidomide—leprosy	0.000768	0.0032	CcSEcCtD
Mirtazapine—Urethral disorder—Thalidomide—leprosy	0.000764	0.00319	CcSEcCtD
Mirtazapine—SLC6A4—nervous system—leprosy	0.000747	0.00776	CbGeAlD
Mirtazapine—HTR2B—nervous system—leprosy	0.00074	0.00769	CbGeAlD
Mirtazapine—Erythema multiforme—Thalidomide—leprosy	0.000737	0.00307	CcSEcCtD
Mirtazapine—HTR2A—eye—leprosy	0.000735	0.00763	CbGeAlD
Mirtazapine—Eye disorder—Thalidomide—leprosy	0.000728	0.00304	CcSEcCtD
Mirtazapine—Tinnitus—Thalidomide—leprosy	0.000727	0.00303	CcSEcCtD
Mirtazapine—Cardiac disorder—Thalidomide—leprosy	0.000723	0.00302	CcSEcCtD
Mirtazapine—ADRA2C—tendon—leprosy	0.000717	0.00745	CbGeAlD
Mirtazapine—Angiopathy—Thalidomide—leprosy	0.000707	0.00295	CcSEcCtD
Mirtazapine—Chills—Thalidomide—leprosy	0.000699	0.00292	CcSEcCtD
Mirtazapine—Arrhythmia—Thalidomide—leprosy	0.000696	0.0029	CcSEcCtD
Mirtazapine—Alopecia—Thalidomide—leprosy	0.000689	0.00287	CcSEcCtD
Mirtazapine—Vomiting—Dapsone—leprosy	0.000688	0.00287	CcSEcCtD
Mirtazapine—Mental disorder—Thalidomide—leprosy	0.000683	0.00285	CcSEcCtD
Mirtazapine—Malnutrition—Thalidomide—leprosy	0.000678	0.00283	CcSEcCtD
Mirtazapine—Headache—Dapsone—leprosy	0.000677	0.00283	CcSEcCtD
Mirtazapine—SLC6A2—testis—leprosy	0.00067	0.00696	CbGeAlD
Mirtazapine—Flatulence—Thalidomide—leprosy	0.000668	0.00279	CcSEcCtD
Mirtazapine—Tension—Thalidomide—leprosy	0.000666	0.00278	CcSEcCtD
Mirtazapine—Dysgeusia—Thalidomide—leprosy	0.000664	0.00277	CcSEcCtD
Mirtazapine—HTR1A—nervous system—leprosy	0.000663	0.00689	CbGeAlD
Mirtazapine—Nervousness—Thalidomide—leprosy	0.000659	0.00275	CcSEcCtD
Mirtazapine—SLC6A2—nervous system—leprosy	0.000658	0.00683	CbGeAlD
Mirtazapine—Back pain—Thalidomide—leprosy	0.000656	0.00274	CcSEcCtD
Mirtazapine—HTR7—testis—leprosy	0.000646	0.00671	CbGeAlD
Mirtazapine—Nausea—Dapsone—leprosy	0.000642	0.00268	CcSEcCtD
Mirtazapine—Tremor—Thalidomide—leprosy	0.000636	0.00265	CcSEcCtD
Mirtazapine—HTR7—nervous system—leprosy	0.000634	0.00659	CbGeAlD
Mirtazapine—Ill-defined disorder—Thalidomide—leprosy	0.000629	0.00262	CcSEcCtD
Mirtazapine—Anaemia—Thalidomide—leprosy	0.000627	0.00261	CcSEcCtD
Mirtazapine—Agitation—Thalidomide—leprosy	0.000623	0.0026	CcSEcCtD
Mirtazapine—Malaise—Thalidomide—leprosy	0.000612	0.00255	CcSEcCtD
Mirtazapine—ADRA1A—nervous system—leprosy	0.000611	0.00635	CbGeAlD
Mirtazapine—DRD2—testis—leprosy	0.000611	0.00635	CbGeAlD
Mirtazapine—Vertigo—Thalidomide—leprosy	0.000609	0.00254	CcSEcCtD
Mirtazapine—Syncope—Thalidomide—leprosy	0.000608	0.00254	CcSEcCtD
Mirtazapine—Leukopenia—Thalidomide—leprosy	0.000607	0.00253	CcSEcCtD
Mirtazapine—Palpitations—Thalidomide—leprosy	0.000599	0.0025	CcSEcCtD
Mirtazapine—DRD2—nervous system—leprosy	0.000599	0.00623	CbGeAlD
Mirtazapine—Loss of consciousness—Thalidomide—leprosy	0.000596	0.00249	CcSEcCtD
Mirtazapine—ADRA2C—testis—leprosy	0.000594	0.00617	CbGeAlD
Mirtazapine—Cough—Thalidomide—leprosy	0.000592	0.00247	CcSEcCtD
Mirtazapine—Convulsion—Thalidomide—leprosy	0.000588	0.00245	CcSEcCtD
Mirtazapine—Hypertension—Thalidomide—leprosy	0.000586	0.00244	CcSEcCtD
Mirtazapine—ADRA2C—nervous system—leprosy	0.000583	0.00605	CbGeAlD
Mirtazapine—HRH1—tendon—leprosy	0.000582	0.00605	CbGeAlD
Mirtazapine—Arthralgia—Thalidomide—leprosy	0.000578	0.00241	CcSEcCtD
Mirtazapine—Myalgia—Thalidomide—leprosy	0.000578	0.00241	CcSEcCtD
Mirtazapine—Chest pain—Thalidomide—leprosy	0.000578	0.00241	CcSEcCtD
Mirtazapine—Anxiety—Thalidomide—leprosy	0.000576	0.0024	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000574	0.00239	CcSEcCtD
Mirtazapine—ADRA2A—tendon—leprosy	0.000572	0.00594	CbGeAlD
Mirtazapine—Discomfort—Thalidomide—leprosy	0.000571	0.00238	CcSEcCtD
Mirtazapine—Dry mouth—Thalidomide—leprosy	0.000565	0.00236	CcSEcCtD
Mirtazapine—Confusional state—Thalidomide—leprosy	0.000558	0.00233	CcSEcCtD
Mirtazapine—Oedema—Thalidomide—leprosy	0.000554	0.00231	CcSEcCtD
Mirtazapine—CYP2C8—testis—leprosy	0.000551	0.00572	CbGeAlD
Mirtazapine—Infection—Thalidomide—leprosy	0.00055	0.00229	CcSEcCtD
Mirtazapine—Shock—Thalidomide—leprosy	0.000545	0.00227	CcSEcCtD
Mirtazapine—Nervous system disorder—Thalidomide—leprosy	0.000543	0.00226	CcSEcCtD
Mirtazapine—Thrombocytopenia—Thalidomide—leprosy	0.000542	0.00226	CcSEcCtD
Mirtazapine—Tachycardia—Thalidomide—leprosy	0.00054	0.00225	CcSEcCtD
Mirtazapine—Skin disorder—Thalidomide—leprosy	0.000538	0.00224	CcSEcCtD
Mirtazapine—Hyperhidrosis—Thalidomide—leprosy	0.000535	0.00223	CcSEcCtD
Mirtazapine—Anorexia—Thalidomide—leprosy	0.000528	0.0022	CcSEcCtD
Mirtazapine—Hypotension—Thalidomide—leprosy	0.000517	0.00216	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000504	0.0021	CcSEcCtD
Mirtazapine—Insomnia—Thalidomide—leprosy	0.000501	0.00209	CcSEcCtD
Mirtazapine—Paraesthesia—Thalidomide—leprosy	0.000497	0.00207	CcSEcCtD
Mirtazapine—Dyspnoea—Thalidomide—leprosy	0.000494	0.00206	CcSEcCtD
Mirtazapine—Somnolence—Thalidomide—leprosy	0.000492	0.00205	CcSEcCtD
Mirtazapine—Dyspepsia—Thalidomide—leprosy	0.000487	0.00203	CcSEcCtD
Mirtazapine—HTR2A—tendon—leprosy	0.000486	0.00505	CbGeAlD
Mirtazapine—HRH1—testis—leprosy	0.000482	0.00501	CbGeAlD
Mirtazapine—Decreased appetite—Thalidomide—leprosy	0.000481	0.00201	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Thalidomide—leprosy	0.000478	0.00199	CcSEcCtD
Mirtazapine—Fatigue—Thalidomide—leprosy	0.000477	0.00199	CcSEcCtD
Mirtazapine—ADRA2A—testis—leprosy	0.000474	0.00492	CbGeAlD
Mirtazapine—Constipation—Thalidomide—leprosy	0.000473	0.00197	CcSEcCtD
Mirtazapine—Pain—Thalidomide—leprosy	0.000473	0.00197	CcSEcCtD
Mirtazapine—HRH1—nervous system—leprosy	0.000473	0.00492	CbGeAlD
Mirtazapine—ADRA2A—nervous system—leprosy	0.000465	0.00483	CbGeAlD
Mirtazapine—Feeling abnormal—Thalidomide—leprosy	0.000456	0.0019	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Thalidomide—leprosy	0.000453	0.00189	CcSEcCtD
Mirtazapine—Urticaria—Thalidomide—leprosy	0.00044	0.00183	CcSEcCtD
Mirtazapine—Abdominal pain—Thalidomide—leprosy	0.000438	0.00183	CcSEcCtD
Mirtazapine—Body temperature increased—Thalidomide—leprosy	0.000438	0.00183	CcSEcCtD
Mirtazapine—Hypersensitivity—Thalidomide—leprosy	0.000408	0.0017	CcSEcCtD
Mirtazapine—HTR2A—testis—leprosy	0.000403	0.00419	CbGeAlD
Mirtazapine—Asthenia—Thalidomide—leprosy	0.000397	0.00166	CcSEcCtD
Mirtazapine—HTR2A—nervous system—leprosy	0.000395	0.00411	CbGeAlD
Mirtazapine—Pruritus—Thalidomide—leprosy	0.000392	0.00163	CcSEcCtD
Mirtazapine—Diarrhoea—Thalidomide—leprosy	0.000379	0.00158	CcSEcCtD
Mirtazapine—CYP2D6—testis—leprosy	0.000367	0.00381	CbGeAlD
Mirtazapine—Dizziness—Thalidomide—leprosy	0.000366	0.00153	CcSEcCtD
Mirtazapine—CYP3A4—nervous system—leprosy	0.000366	0.0038	CbGeAlD
Mirtazapine—CYP2D6—nervous system—leprosy	0.00036	0.00374	CbGeAlD
Mirtazapine—Vomiting—Thalidomide—leprosy	0.000352	0.00147	CcSEcCtD
Mirtazapine—Rash—Thalidomide—leprosy	0.000349	0.00146	CcSEcCtD
Mirtazapine—Dermatitis—Thalidomide—leprosy	0.000349	0.00145	CcSEcCtD
Mirtazapine—Headache—Thalidomide—leprosy	0.000347	0.00145	CcSEcCtD
Mirtazapine—Nausea—Thalidomide—leprosy	0.000329	0.00137	CcSEcCtD
